Yuan Liang Selected Research

Postoperative Hemorrhage

8/2019	Efficacy and safety of tranexamic acid usage in patients undergoing posterior lumbar fusion: a meta-analysis.
1/2018	A systematic review of tranexamic acid usage in patients undergoing femoral fracture surgery.
5/2017	Efficacy and safety of intravenous tranexamic acid administration in patients undergoing hip fracture surgery for hemostasis: A meta-analysis.
4/2017	Timing of tourniquet release in total knee arthroplasty: A meta-analysis.
1/2017	Combined application versus topical and intravenous application of tranexamic acid following primary total hip arthroplasty: a meta-analysis.
12/2016	Intravenous versus topical tranexamic acid in primary total hip replacement: A meta-analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yuan Liang Research Topics

Disease

31	Neoplasms (Cancer) 01/2022 - 01/2011
9	Inflammation (Inflammations) 11/2021 - 08/2013
8	Type 2 Diabetes Mellitus (MODY) 03/2019 - 02/2015
6	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 01/2017
6	Wounds and Injuries (Trauma) 11/2021 - 04/2017
6	Postoperative Hemorrhage 08/2019 - 12/2016
5	Neoplasm Metastasis (Metastasis) 01/2022 - 12/2013
4	Non-alcoholic Fatty Liver Disease 01/2022 - 01/2016
4	Coronary Disease (Coronary Heart Disease) 08/2021 - 11/2015
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020 - 01/2012
4	Infections 01/2020 - 01/2016
4	Hypertension (High Blood Pressure) 01/2018 - 12/2016
3	Atopic Dermatitis (Atopic Eczema) 01/2022 - 01/2019
3	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2017
3	COVID-19 01/2022 - 01/2021
3	Carcinoma (Carcinomatosis) 01/2022 - 11/2010
3	Fibrosis (Cirrhosis) 02/2021 - 08/2014
3	Adenocarcinoma of Lung 09/2020 - 10/2019
3	Liver Neoplasms (Liver Cancer) 01/2019 - 01/2014
3	Diabetes Mellitus 01/2019 - 10/2013
3	Venous Thrombosis (Deep-Vein Thrombosis) 04/2017 - 12/2016
3	Cicatrix (Scar) 06/2016 - 04/2014
2	Carcinogenesis 01/2022 - 01/2011
2	Osteosarcoma (Osteogenic Sarcoma) 01/2022 - 12/2021
2	Atherosclerosis 01/2022 - 08/2013
2	Necrosis 01/2022 - 09/2005
2	Lymphatic Metastasis 01/2022 - 01/2020
2	Stomach Neoplasms (Stomach Cancer) 08/2021 - 01/2021
2	Liver Cirrhosis (Hepatic Cirrhosis) 03/2021 - 01/2019
2	Obesity 01/2021 - 01/2016
2	Lung Neoplasms (Lung Cancer) 01/2021 - 01/2020
2	Malaria 01/2021 - 05/2019
2	Falciparum Malaria (Plasmodium falciparum Malaria) 01/2021 - 01/2020
2	Intervertebral Disc Displacement (Herniated Disc) 08/2019 - 02/2017
2	Lung Injury 03/2019 - 01/2019
2	Stevens-Johnson Syndrome (Lyell's Syndrome) 06/2018 - 07/2017
2	Cardiovascular Diseases (Cardiovascular Disease) 08/2017 - 02/2015
2	Pain (Aches) 02/2017 - 01/2016
2	Pulmonary Embolism 01/2017 - 12/2016
2	Noise-Induced Hearing Loss (Acoustic Trauma) 07/2015 - 10/2011
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 02/2015 - 08/2013
1	Ischemic Stroke 01/2022

Drug/Important Bio-Agent (IBA)

8	Biomarkers (Surrogate Marker)IBA 01/2022 - 06/2013
8	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 10/2013
7	Hemoglobins (Hemoglobin)IBA 01/2020 - 12/2016
6	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 03/2014
5	Proteins (Proteins, Gene)FDA Link 10/2021 - 03/2014
5	ErbB Receptors (EGF Receptor)IBA 01/2021 - 06/2013
5	BilirubinIBA 01/2019 - 01/2016
5	ORALIT (ORS)IBA 01/2018 - 01/2016
4	Cell-Free Nucleic AcidsIBA 01/2022 - 01/2020
4	MicroRNAs (MicroRNA)IBA 12/2021 - 01/2017
4	Tyrosine Kinase InhibitorsIBA 01/2021 - 06/2013
4	Anti-Bacterial Agents (Antibiotics)IBA 11/2020 - 10/2016
4	AntigensIBA 01/2019 - 01/2014
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 05/2010
3	Messenger RNA (mRNA)IBA 12/2021 - 11/2019
3	LipopolysaccharidesIBA 11/2021 - 01/2019
3	Long Noncoding RNAIBA 06/2021 - 01/2020
3	artemisinin (artemisinine)IBA 01/2021 - 05/2019
3	piperaquineIBA 01/2021 - 05/2019
3	Therapeutic UsesIBA 01/2021 - 09/2005
3	Tumor Biomarkers (Tumor Markers)IBA 01/2018 - 01/2014
2	Pharmaceutical PreparationsIBA 01/2022 - 08/2020
2	AntioxidantsIBA 01/2022 - 01/2017
2	Uric Acid (Urate)IBA 01/2022 - 08/2013
2	Blood Glucose (Blood Sugar)IBA 01/2022 - 01/2016
2	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 11/2021 - 09/2021
2	BerberineIBA 11/2021 - 01/2019
2	Immune Checkpoint InhibitorsIBA 10/2021 - 01/2021
2	Neuroprotective AgentsIBA 09/2021 - 11/2020
2	RNA (Ribonucleic Acid)IBA 05/2021 - 01/2021
2	CalciumIBA 04/2021 - 05/2011
2	LipidsIBA 01/2021 - 11/2015
2	Histones (Histone)IBA 01/2021 - 01/2020
2	TriterpenesIBA 01/2021 - 09/2017
2	Phosphotransferases (Kinase)IBA 10/2019 - 01/2019
2	Tranexamic Acid (AMCA)FDA Link 08/2019 - 01/2018
2	CarbohydratesIBA 01/2019 - 01/2018
2	Insulin (Novolin)FDA Link 01/2019 - 01/2019
2	Biological ProductsIBA 09/2018 - 05/2011
2	alpha-Fetoproteins (alpha-Fetoprotein)IBA 01/2018 - 01/2018
2	Carcinoembryonic AntigenIBA 01/2018 - 01/2014
2	Estrogens (Estrogen)FDA Link 08/2017 - 05/2011
2	hydroxycamptothecinumIBA 06/2016 - 04/2014
2	homocamptothecinIBA 06/2016 - 09/2015
2	Sildenafil Citrate (Viagra)FDA Link 07/2015 - 10/2011
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2011 - 11/2010
1	Nonprescription Drugs (Patent Medicines)IBA 01/2022
1	Angong Niuhuang PillIBA 01/2022

Therapy/Procedure

17	Therapeutics 01/2022 - 07/2017
3	Radiotherapy 01/2018 - 08/2012
2	Operative Surgical Procedures 05/2021 - 07/2018
2	Drug Therapy (Chemotherapy) 01/2021 - 01/2012
2	Immunotherapy 01/2021 - 01/2020
2	Transplantation 03/2019 - 09/2014
2	Operative Time 01/2018 - 05/2017
2	Laminectomy 02/2017 - 08/2014
2	Intravenous Administration 01/2017 - 12/2016
1	Traditional Medicine (Folk Remedies) 01/2022